Загрузка...
Voxelotor: A Ray of Hope for Sickle Disease
Sickle cell disease is one challenging blood disorder, affecting around 100,000 people in the United States alone. None of the currently approved drugs can modify the underlying pathology of the disease. Voxelotor, first of its kind, is an orally administered drug that can alter the underlying disea...
Сохранить в:
| Опубликовано в: : | Cureus |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cureus
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100618/ https://ncbi.nlm.nih.gov/pubmed/32257653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.7105 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|